Asia Healthcare Holdings (AHH), the single specialty healthcare delivery platform, has acquired a majority stake in Asian Institute of Nephrology and Urology (AINU), India’s largest single specialty hospital network of Urology & Nephrology Care with a presence in four cities and pioneering work in Robotic Urology Surgery.

AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion. This acquisition and AHH’s foray into Urology and Nephrology segment marks its expansion into a fourth speciality making it the largest and only single speciality healthcare delivery platform in India and the broader Asian sub-continent. AHH was launched in 2017 and since then has scaled enterprises in Oncology (CTSI), Women & Children’s (Motherhood Hospitals), IVF & Fertility (Nova IVF) which have all attained leadership positions within their respective domains.

AINU, founded in 2013 by a team of leading Urologists & Nephrologists led by Dr C Mallikarjuna and Dr P C Reddy, currently operates seven hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai.

“AINU is a distinct single specialty hospital chain in Urology & Nephrology which is built on the foundation of deep clinical expertise and led by clinicians who have decades of experience in this specialty. AINU not only adds a new speciality to the AHH platform but also strengthens our vision of scaling the single specialty healthcare delivery ecosystem in the country. India is amongst the top three nations globally that has the highest incidence Urological disorders, the high incidence of diabetes and hypertension is also accelerating the prevalence chronic kidney disease. We are delighted to partner with AINU and bridge the demand supply gap in the Urology & Nephrology speciality healthcare delivery in the country” said Vishal Bali, Executive Chairman, Asia Healthcare Holdings.  

“Indians have a high incidence of kidney stones, and non-cancerous prostate enlargement issues. Increasingly we have observed a rise in the incidence of Urological cancer in the last decade. Cancer of the prostate and bladder are becoming more common. Our team has performed over 1,000 robotic surgeries for urological cancers. We are making Robotic Urology surgery accessible to patients not just in urban India but also in tier 2 cities. Broadly we see a higher incidence of Uro-Oncology, Uro-Gynaecology and Paediatric Urology in the years ahead. We believe AHH has the legacy and is the right partner for the next phase of growth of our enterprise said Dr C Mallikarjun, Chief Consultant Urologist & Managing Director, AINU.

“Around 10 per cent of the Indian population suffers from Chronic Kidney Disease and every year over one lakh cases of renal failure are reported which makes Nephrology Care a key focus area for patients in India. With increase in chronic kidney diseases, technological advancements in Dialysis and transplants are much needed to improve clinical outcomes and better patient care”” said Dr P.C. Reddy, Senior Urologist& Executive Director, AINU.

In 2022, India recorded approximately 1.89 crores Nephrology and Urology procedures and is projected to grow CAGR of 8-9% over the next five years making it one of the fastest growing specialties in the country. There are 6,000 qualified Urologists and 3,500 Nephrologists in India. Approximately 350 Urologists and 250 nephrologists graduate each year in India and the rise of laparoscopic, endoscopic and robotic surgical options gives a compelling growth opportunity for AINU to scale across the metros and tier 2 cities in the country.